Skip to content

Examination of effectiveness of NAC(N-acetyl cysteine) for PCOS(Polycystic ovary syndrome)patients:Systematic review

Examination of effectiveness of NAC(N-acetyl cysteine) for PCOS(Polycystic ovary syndrome)patients:Systematic review - Efficacy of NAC(N-acetyl cysteine)for PCOS(Polycystic ovary syndrome)patients:Systematic review

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000042613
Enrollment
100
Registered
2021-03-31
Start date
2020-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS(Polycystic ovary syndrome)

Interventions

None listed

Sponsors

Yokohama University of Pharmacy
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All studies using NAC to treat PCOS

Exclusion criteria

Exclusion criteria: Studies that do not use NAC to treat PCOS

Design outcomes

Primary

MeasureTime frame
Ovulation rate

Countries

Japan

Contacts

Public ContactHayamizu Kohsuke

Yokohama University of Pharmacy Laboratory of Food Chemistry

k.hayamizu@hamayaku.ac.jp045-859-1300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026